查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701304

臨床試驗中心化驗服務市場規模、佔有率、趨勢分析報告：按階段、服務、適應症、最終用途、地區、細分市場預測，2025-2030

Clinical Trial Central Laboratory Services Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Service, By Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗中心化驗服務市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球臨床試驗中心化驗服務市場規模預計到2030年將達到69.7億美元，2025年至2030年期間的複合年成長率為9.8%。

這一市場受到臨床試驗數量的增加、基於生物標記的測試需求的不斷成長、嚴格的監管要求以及分散測試的日益普及的推動。此外，人工智慧主導的分析、自動化和數位實驗室管理系統等技術進步將進一步提高效率、縮短週轉時間並改善整體測試結果。

由於藥物開發項目的增加和研發投入的增加，市場正在迅速擴大。製藥和生物技術公司正在進行更多的臨床試驗，將創新治療方法推向市場，進一步推動對專業實驗室服務的需求。基於生物標記的測試、基因組分析和藥物動力學研究在臨床試驗中變得越來越重要，並且需要先進的實驗室能力。監管機構對藥品核准實施嚴格的指導方針，因此集中化驗服務對於確保合規性、數據準確性和標準化測試程序至關重要。

此外，向分散和虛擬臨床試驗的轉變正在進一步改變該行業，推動對高效樣本採集、即時數據整合和遠端測試解決方案的需求。人工智慧主導的分析、自動化和數位實驗室管理系統等新技術將提高業務效率並加快測試時間。此外，製藥公司、CRO 和中央實驗室提供者之間的策略聯盟將加強實驗室網路並擴大全球測試能力。人們對個人化醫療和精準治療的日益關注繼續推動對高品質化驗服務的需求，從而刺激該行業的顯著成長。

市場的主要參與者正在採取各種策略來鞏固其市場地位。這包括策略夥伴關係、併購和擴大我們的實驗室網路以加強我們的全球影響力。該公司還投資於人工智慧主導的分析、自動化和基於生物標記的測試等先進技術，以提高效率和準確性。例如，2025 年 2 月，LabConnect 與 Sapio Sciences 簽署了夥伴關係協議，以實施實驗室資訊管理系統 (LIMS)。此次合作旨在進一步數位化複雜的研究工作流程、簡化樣本追蹤並增強 LabConnect業務中的資料管理。

臨床試驗化驗服務市場報告重點

  • 從服務角度來看，由於基因組和分子檢測的進步，生物標記檢測服務佔據了市場主導地位。監管機構也鼓勵基於生物標記的藥物核准，進一步刺激市場擴張。
  • 按階段分類，由於樣本量大且測試要求廣泛，III 期將在 2024 年佔據最大的市場佔有率。後期臨床試驗和監管要求的增加進一步推動了對中央實驗室服務的需求。
  • 根據適應症，由於癌症發病率上升和新治療方法臨床試驗數量的增加，冷凍在 2024 年佔據了最大的市場佔有率。人們對個人化醫療和基於生物標記的診斷的日益關注推動了對專門實驗室測試的需求。
  • 根據最終用途，製藥和生物製藥公司憑藉其高額的研發投入和廣泛的臨床試驗管道，在 2024 年佔據了最大的市場佔有率。對專業檢測、生物標記分析和精準醫療的需求不斷成長，推動了對集中實驗室的更大依賴。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術進步
    • 人工智慧與數位科技的融合
  • 定價模式分析
  • 2024年臨床試驗量分析
    • 各地區臨床試驗總數（2024年）
    • 各階段臨床試驗總數（2024 年）
    • 依研究設計分類的臨床試驗總數（2024 年）
    • 按主要治療領域分類的臨床試驗總數（2024 年）
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章臨床試驗中心化驗服務市場：依服務估算與趨勢分析

  • 細分儀表板
  • 臨床試驗化驗服務市場：服務變化分析
  • 2018 年至 2030 年臨床試驗中心化驗服務規模及趨勢分析（依服務）
  • 生物標記檢測服務
  • 微生物學服務
  • 解剖病理學/組織學
  • 藥物動力學/動態（PK/PD）
  • 基因組和分子檢測
  • 樣本收集和處理
  • 物流和樣品管理
  • 數據管理和報告
  • 其他

第5章：臨床試驗中心化驗服務市場：各階段的估計與趨勢分析

  • 細分儀表板
  • 臨床試驗中心化驗服務市場：階段波動分析
  • 臨床試驗中心化驗服務規模及趨勢分析（分階段）（2018-2030）
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第6章臨床試驗中心化驗服務市場：按適應症的估計和趨勢分析

  • 細分儀表板
  • 臨床試驗中心化驗服務市場：適應症變異分析
  • 2018 年至 2030 年臨床試驗中心化驗服務規模及趨勢分析（依適應症）
  • 腫瘤學
  • 心臟病學
  • 神經病學
  • 感染疾病
  • 免疫學與自體免疫疾病
  • 其他

第7章臨床試驗中心化驗服務市場：按最終用途的估計和趨勢分析

  • 細分儀表板
  • 臨床試驗化驗服務市場：最終用途變異分析
  • 2018 年至 2030 年臨床試驗中心化驗服務規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 受託研究機構
  • 其他

第8章：臨床試驗中心化驗服務市場：區域估計與趨勢分析

  • 區域儀表板
  • 2018年至2030年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭格局

  • 公司分類
  • 2024年企業市場分析
  • 公司簡介
    • Labcorp
    • ICON plc
    • Eurofins Scientific
    • Thermo Fisher Scientific Inc.
    • Medpace
    • Q2 Solutions
    • Syneos Health
    • Charles River Laboratories
    • SGS
    • LabConnect
Product Code: GVR-4-68040-531-5

Clinical Trial Central Laboratory Services Market Growth & Trends:

The global clinical trial central laboratory services market size is expected to reach USD 6.97 billion by 2030, growing at a CAGR of 9.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing number of clinical trials, rising demand for biomarker-based testing, stringent regulatory requirements, and growing adoption of decentralized trials. Moreover, technological advancements such as AI-driven analytics, automation, and digital lab management systems further enhance efficiency, reduce turnaround times, and improve overall trial outcomes.

The market is expanding rapidly due to the increasing number of drug development programs and growing investments in research and development. Pharmaceutical and biotechnology companies are conducting more clinical trials to bring innovative therapies to market, further driving the demand for specialized laboratory services. Biomarker-based testing, genomic analysis, and pharmacokinetics studies are becoming essential for clinical trials, requiring advanced lab capabilities. Regulatory authorities are imposing stringent guidelines for drug approval, making centralized laboratory services critical for ensuring compliance, data accuracy, and standardized testing procedures.

Furthermore, the shift toward decentralized and virtual trials further transforms the industry, increasing the need for efficient sample collection, real-time data integration, and remote testing solutions. Emerging technologies such as AI-driven analytics, automation, and digital lab management systems enhance operational efficiency and accelerate trial timelines. Moreover, strategic collaborations between pharmaceutical companies, CROs, and central lab providers strengthen laboratory networks and expand global testing capabilities. The growing focus on personalized medicine and precision therapies continues to fuel demand for high-quality laboratory services, accelerating the industry's significant growth.

Key market players are adopting various strategies to strengthen their market position. These include strategic partnerships, mergers and acquisitions, and expanding laboratory networks to enhance global reach. Companies also invest in advanced technologies such as AI-driven analytics, automation, and biomarker-based testing to improve efficiency and accuracy. For instance, in February 2025, LabConnect entered into a partnership agreement with Sapio Sciences to implement a Laboratory Information Management System (LIMS). This collaboration aims to further digitally transform complex research workflows, streamlining sample tracking and enhancing data management within LabConnect's operations.

Clinical Trial Central Laboratory Services Market Report Highlights:

  • Based on service, biomarker testing services dominated the market due to genomic and molecular testing advancements. Regulatory agencies are also encouraging biomarker-based drug approvals, further fueling the market expansion
  • Based on the phase, Phase III held the largest market share in 2024 due to the high volume of samples and extensive testing requirements. The growing number of late-stage trials and regulatory mandates further drive demand for central lab services
  • Based on Indication, frozen held the largest market share in 2024 due to the rising prevalence of cancer and increasing clinical trials for novel therapies. The growing focus on personalized medicine and biomarker-based diagnostics has amplified the demand for specialized laboratory testing
  • Based on end use, pharmaceutical & biopharmaceutical companies held the largest market share in 2024 due to their high R&D investments and extensive clinical trial pipelines. The increasing demand for specialized testing, biomarker analysis, and precision medicine further strengthened their reliance on central labs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Technological Advancements
    • 3.4.1. Integration of AI and Digital Technologies
  • 3.5. Pricing Model Analysis
  • 3.6. Clinical Trials Volume Analysis, 2024
    • 3.6.1. Total Number of Clinical Trials, by Region (2024)
    • 3.6.2. Total Number of Clinical Trials, by Phase (2024)
    • 3.6.3. Total Number of Clinical Trials, by Study Design (2024)
    • 3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
  • 3.7. Industry Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis
    • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Central Laboratory Services Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Clinical Trial Central Laboratory Services Market; Service Movement Analysis
  • 4.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Biomarker Testing Services
    • 4.4.1. Biomarker testing services market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Microbiology Services
    • 4.5.1. Microbiology services market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Anatomic Pathology/Histology
    • 4.6.1. Anatomic pathology/histology market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Pharmacokinetics/Pharmacodynamics (PK/PD)
    • 4.7.1. Pharmacokinetics/Pharmacodynamics (PK/PD) market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.8. Genomic and Molecular Testing
    • 4.8.1. Genomic and molecular testing market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.9. Sample Collection and Processing
    • 4.9.1. Sample collection and processing market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.10. Logistics & Sample Management
    • 4.10.1. Logistics & sample management market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.11. Data Management & Reporting
    • 4.11.1. Data management & reporting market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.12. Others
    • 4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Central Laboratory Services Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Clinical Trial Central Laboratory Services Market; Phase Movement Analysis
  • 5.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Central Laboratory Services Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Clinical Trial Central Laboratory Services Market; Indication Movement Analysis
  • 6.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Cardiology
    • 6.5.1. Cardiology market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Neurology
    • 6.6.1. Neurology market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Infectious Diseases
    • 6.7.1. Infectious Diseases market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Immunology & Autoimmune Diseases
    • 6.8.1. Immunology & autoimmune diseases market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Central Laboratory Services Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Clinical Trial Central Laboratory Services Market; End Use Movement Analysis
  • 7.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Contract Research Organizations
    • 7.5.1. Contract Research Organizations market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Central Laboratory Services Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Germany clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. UK clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. South Korea clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Australia clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Thailand clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Position Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Labcorp
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Service benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. ICON plc
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Service benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Eurofins Scientific
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Service benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Thermo Fisher Scientific Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Service benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medpace
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Service benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Q2 Solutions
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Service benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Syneos Health
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Service benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Charles River Laboratories
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Service benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. SGS
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Service benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. LabConnect
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Service benchmarking
      • 9.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Clinical Trial Central Laboratory Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 11 North America Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 12 North America Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 14 U.S. Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 15 U.S. Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 Canada Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 19 Canada Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 20 Canada Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Mexico Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 23 Mexico Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 24 Mexico Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 27 Europe Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 28 Europe Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 29 Europe Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 31 UK Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 32 UK Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 33 UK Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 Germany Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 36 Germany Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 37 Germany Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 39 France Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 40 France Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 41 France Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Italy Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 44 Italy Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 45 Italy Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 47 Spain Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 48 Spain Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 51 Denmark Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 52 Denmark Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 53 Denmark Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 55 Sweden Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 56 Sweden Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 57 Sweden Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 59 Norway Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 60 Norway Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 61 Norway Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Japan Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 69 Japan Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 70 Japan Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 72 China Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 73 China Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 74 China Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 76 India Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 77 India Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 78 India Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 80 Australia Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 81 Australia Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 82 Australia Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 South Korea Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 85 South Korea Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 86 South Korea Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 88 Thailand Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 89 Thailand Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 90 Thailand Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 93 Latin America Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 94 Latin America Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 95 Latin America Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 97 Brazil Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 98 Brazil Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 99 Brazil Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 101 Argentina Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 102 Argentina Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 103 Argentina Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 MEA Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 MEA Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 106 MEA Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 107 MEA Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 108 South Africa Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 109 South Africa Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 111 South Africa Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 116 UAE Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 117 UAE Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 119 UAE Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Central Laboratory Services Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Clinical Trial Central Laboratory Services Market: Service Key Takeaways
  • Fig. 14 Global Clinical Trial Central Laboratory Services Market: Service Movement Analysis
  • Fig. 15 Global Clinical Trial Central Laboratory Services Market, for Biomarker Testing Services, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Central Laboratory Services Market, for Microbiology Services, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Central Laboratory Services Market, for Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Central Laboratory Services Market, for Pharmacokinetics/Pharmacodynamics (PK/PD), 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Central Laboratory Services Market, for Genomic and Molecular Testing, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Central Laboratory Services Market, for Sample Collection and Processing, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Central Laboratory Services Market, for Monitoring & Visibility Solutions, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Central Laboratory Services Market, for Logistics & Sample Management, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Central Laboratory Services Market, for Data Management & Reporting, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Central Laboratory Services Market: Phase Key Takeaways
  • Fig. 26 Global Clinical Trial Central Laboratory Services Market: Phase Movement Analysis
  • Fig. 27 Global Clinical Trial Central Laboratory Services Market, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Central Laboratory Services Market, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Central Laboratory Services Market, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 30 Global Clinical Trial Central Laboratory Services Market, for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 31 Global Clinical Trial Central Laboratory Services Market: Indication Key Takeaways
  • Fig. 32 Global Clinical Trial Central Laboratory Services Market, Indication Movement Analysis
  • Fig. 33 Global Clinical Trial Central Laboratory Services Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 34 Global Clinical Trial Central Laboratory Services Market, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 35 Global Clinical Trial Central Laboratory Services Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 36 Global Clinical Trial Central Laboratory Services Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 37 Global Clinical Trial Central Laboratory Services Market, for Immunology & Autoimmune Diseases, 2018 - 2030 (USD Million)
  • Fig. 38 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Global Clinical Trial Central Laboratory Services Market: End Use Key Takeaways
  • Fig. 40 Global Clinical Trial Central Laboratory Services Market, End Use Movement Analysis
  • Fig. 41 Global Clinical Trial Central Laboratory Services Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 42 Global Clinical Trial Central Laboratory Services Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Fig. 43 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 Regional Outlook, 2024 & 2030
  • Fig. 46 North America Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 50 Europe Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 51 Germany Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 52 UK Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 53 France Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 54 Italy Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 55 Spain Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 58 Norway Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 61 China Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 62 India Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 72 UAE Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)